Recombinant Human CDC25B Protein，N-His

CDC25B is a pivotal protein belonging to the CDC25 phosphatase family, which plays a crucial role in the regulation of the cell cycle by dephosphorylating cyclin-dependent kinase (CDK) proteins, thereby activating them. Research on CDC25B has gained significant attention due to its involvement in cell cycle progression, particularly in the G2/M transition, where it helps ensure that cells only divide when they are ready. Dysregulation of CDC25B has been implicated in various cancers, as aberrant activation can lead to uncontrolled cell proliferation. This has fueled investigations into CDC25B as a potential therapeutic target and biomarker for cancer diagnosis and prognosis. Moreover, understanding the structure-function relationships of CDC25B through recombinant protein studies can provide insights into its regulatory mechanisms and interactions with other cellular components. Efforts to produce CDC25B as a recombinant protein have facilitated high-throughput screening for small molecules that can modulate its activity, leading to the development of novel anticancer strategies. These studies not only contribute to our understanding of cell cycle regulation but also pave the way for innovative therapeutic interventions targeting CDC25B in oncological contexts. Thus, CDC25B remains a focal point of research aimed at elucidating its fundamental role in cell cycle control and its implications in cancer biology.